Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Livio

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Swiss Medical Weekly|June 24, 2022
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipientFrançois R Girardin, Alexandar Tzankov, Giuseppe Pantaleo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 5, 2023
Joint fluid concentrations of amphotericin B after local application with calcium sulphate-report of 2 casesLara Pozzi, Michel Schläppi, Françoise Livio, et al.
Expert Review of Clinical Pharmacology|April 28, 2017
Guidance to develop individual dose recommendations for patients on chronic hemodialysisVerena Gotta, Kim Dao, Frédérique Rodieux, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2026
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?Dela Wordi, Hong-Tham Nguyen, Françoise Livio, et al.
Neurology|March 13, 2025
Initiating or Resuming Cancer Treatment After Ischemic Stroke and Clinical OutcomesGianluca Costamagna, Andreas F Hottinger, Davide Strambo, et al.
Revue Medicale Suisse|February 2, 2022
[Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]Valérie Favre, Pierre Ekobena, Haithem Chtioui, et al.
Antiviral Therapy|August 23, 2012
Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosingMirjam de Roche, Marco Siccardi, Marcel Stoeckle, et al.
Revue Medicale Suisse|March 8, 2016
[Pharmacovigilance update]Kim Dao, Haithem Chtioui, Laura E Rothuizen, et al.
Revue Medicale Suisse|March 25, 2015
[Pharmacovigilance update]Nathalie Fogarasi Szabo, Léonore Diezi, Laurie Delenclos, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Swiss Medical Weekly|June 24, 2022
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipientFrançois R Girardin, Alexandar Tzankov, Giuseppe Pantaleo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 5, 2023
Joint fluid concentrations of amphotericin B after local application with calcium sulphate-report of 2 casesLara Pozzi, Michel Schläppi, Françoise Livio, et al.
Expert Review of Clinical Pharmacology|April 28, 2017
Guidance to develop individual dose recommendations for patients on chronic hemodialysisVerena Gotta, Kim Dao, Frédérique Rodieux, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2026
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?Dela Wordi, Hong-Tham Nguyen, Françoise Livio, et al.
Neurology|March 13, 2025
Initiating or Resuming Cancer Treatment After Ischemic Stroke and Clinical OutcomesGianluca Costamagna, Andreas F Hottinger, Davide Strambo, et al.
Revue Medicale Suisse|February 2, 2022
[Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]Valérie Favre, Pierre Ekobena, Haithem Chtioui, et al.
Antiviral Therapy|August 23, 2012
Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosingMirjam de Roche, Marco Siccardi, Marcel Stoeckle, et al.
Revue Medicale Suisse|March 8, 2016
[Pharmacovigilance update]Kim Dao, Haithem Chtioui, Laura E Rothuizen, et al.
Revue Medicale Suisse|March 25, 2015
[Pharmacovigilance update]Nathalie Fogarasi Szabo, Léonore Diezi, Laurie Delenclos, et al.
Pageof 5